Open main menu
Home
Random
Donate
Recent changes
Special pages
Community portal
Preferences
About Stockhub
Disclaimers
Search
User menu
Talk
Contributions
Create account
Log in
Editing
Eli Lilly and Company
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Corporate Strategy == Eli Lilly's corporate strategy: * Focus on innovation: Eli Lilly is committed to investing in research and development to discover and develop new medicines. The company has a strong track record of innovation, and it has launched several major new products in recent years, including Trulicity, Verzenio, and Taltz. * Expand into new markets: Eli Lilly is expanding its presence in emerging markets such as China and India. The company is also investing in new channels of distribution, such as e-commerce and mobile health. * Drive growth through partnerships: Eli Lilly is partnering with other companies to develop new products and technologies. The company has partnered with companies such as Alnylam Pharmaceuticals and Innoviva to develop new treatments for diseases such as Alzheimer's and hepatitis C. * Strengthen its commercial capabilities: Eli Lilly is investing in its commercial capabilities to improve its ability to bring new products to market and to grow its existing business. The company is also investing in its digital capabilities to improve its ability to interact with patients and healthcare providers. Eli Lilly's corporate strategy is focused on innovation, expansion, partnerships, and commercial capabilities. The company is well-positioned to continue growing in the years to come, driven by its strong pipeline of new products and its expanding presence in emerging markets. Here are some of the specific goals of Eli Lilly's corporate strategy: * Launch 10 new products by 2025. * Generate $50 billion in revenue by 2025. * Expand its presence in emerging markets to 50% of its total revenue by 2025. * Partner with 100 companies by 2025. * Improve its commercial capabilities by 20% by 2025. Eli Lilly is committed to achieving these goals and to becoming a leading pharmaceutical company in the world.
Summary:
Please note that all contributions to Stockhub may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Stockhub:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)